drugset

drugset / Trial / NCT04351295

Efficacy of Faviprevir in COVID-19 Treatment

NCT04351295 ↗

Phase 2/3 Completed 92 enrolled Tanta University

RandomizedParallel-groupOpen-labelTreatment

Summary

Faviprevir in COVID-19 treatment

Timeline

Start: 2020-04-20
Primary completion: 2020-09-28
Completion: 2020-09-28

Publications

Dabbous HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, Ebeid FFS, El Ghafar MSA, Soliman S, Elbahnasawy M, Badawi R, Tageldin MA. Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol. 2021 Mar;166(3):949-954. doi: 10.1007/s00705-021-04956-9. Epub 2021 Jan 25.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Chloroquine	Small molecule	—	Oral
Subject	Favipiravir	Small molecule	—	—

Indications